Condylox

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA020529 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Condylox Gel 0.5% Is Indicated For The Topical Treatment Of Anogenital Warts (External Genital Warts And Perianal Warts). This Product Is Not Indicated In The Treatment Of Mucous Membrane Warts (See Precautions ). Diagnosis Although Anogenital Warts Have A Characteristic Appearance, Histopathologic Confirmation Should Be Obtained If There Is Any Doubt Of The Diagnosis. Differentiating Warts From Squamous Cell Carcinoma And "bowenoid Papulosis" Is Of Particular Concern. Squamous Cell Carcinoma May Also Be Associated With Human Papillomavirus Which Should Not Be Treated With Condylox Gel 0.5%.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Podofilox PODOFILOX ZINC3861806

Comments